Strategies for Ensuring Biomanufacturing Resilience for Biologics

by Oliver Prince, Ph.D. | August 31, 2023


There is consensus among the global health community that long-term collaboration in resilient biomanufacturing capacity and supply chains is needed to ensure the reliable delivery of health technologies such as vaccines, even during crisis conditions.

This paper highlights strategies that are essential to achieving this outcome, drawn from the experience of our company during the global pandemic response and looking forward to how governments and the private sector, including profit and not-for-profit private health actors, can most effectively work together to deliver healthcare post-pandemic. The strategies focus on vaccines, monoclonal antibodies, and new modalities manufactured by biotechnology companies and institutes.

Learn more here.

Senior Consultant

Oliver Prince, Ph.D. is a Senior Consultant, supporting vaccine and monoclonal antibodies within

Merck KGaA, Darmstadt, Germany's
bioprocessing group. Currently, he focuses on “connecting dots” by leading strategic initiatives, supporting go-to-market strategies, as well as supporting customers to build and optimize their manufacturing processes.

Related Posts

Vaccine Maker’s Toolkit: Strategies For Manufacturing And Supply Management

This collection of insights, produced through a partnership between

Merck KGaA, Darmstadt, Germany
,[geot_filter region="north-america" country=""...


In this webinar, join industry experts to learn about strategies to accelerate mRNA therapies and enable scalability and...

Improved endotoxin removal using ecofriendly detergents for intensified plasmid capture

Purification efficiency evaluated endotoxin and host cell protein (HCP) clearance, plasmid yield, potential interference of the detergents with...

Biopharma’s evolution: learnings from the pandemic for a revived regulatory landscape

The covid-19 pandemic forced rapid vaccine development and market approval, shortening a process that normally takes years to...

Post Pandemic: How a new era of supplier-vender collaboration is transforming Biopharma

Check out this article where

's Eva Schaefer, Director of Supply Robustness,...

Strengthening the CDMO-Sponsor Partnership with Improved Data Sharing and Collaboration

Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous...

Scroll to Top